Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: A systematic literature review

Exercise Immunology Review

Volumn 20, Issue , 2014, Pages 94-116

  Nijs, Jo ^a,b,c   Nees, Andrea ^b   Paul, Lorna ^d   De Kooning, Margot ^a,b,c   Ickmans, Kelly ^a,b,c   Meeus, Mira ^a,e,f   Van Oosterwijck, Jessica ^a,b,e  

^a Pain in Motion Research Group   (United States)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e GHENT UNIVERSITY   (Belgium)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Complement system; Cytokine; Exercise; Fatigue; Genetics; Inflammation; Oxidative stress; Pain; Physical activity

Indexed keywords

ALPHA INTERFERON; ASCORBIC ACID; CHAPERONIN 60; COMPLEMENT COMPONENT C4A; GAMMA INTERFERON; GLYCOPROTEIN GP 130; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENT; CYTOKINE; IL10 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ARTICLE; CHRONIC FATIGUE SYNDROME; COMPLEMENT SYSTEM; CYTOKINE RESPONSE; EXERCISE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE; MALAISE; MONOCYTE; NITROSATIVE STRESS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SYSTEMATIC REVIEW; ADULT; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; EVIDENCE BASED MEDICINE; EXERCISE TEST; FEMALE; FORECASTING; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; LEUKOCYTE; LIPID PEROXIDATION; MALE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION (PROCESS); SEX DIFFERENCE; STATISTICAL BIAS;

ADULT; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; EVIDENCE-BASED MEDICINE; EXERCISE; EXERCISE TEST; FATIGUE SYNDROME, CHRONIC; FEMALE; FORECASTING; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-10; LEUKOCYTES; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RESEARCH DESIGN; SEX FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84904399161     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Bazelmans E, Bleijenberg G, Voeten MJ, van der Meer JW, and Folgering H. Impact of a maximal exercise test on symptoms and activity in chronic fatigue syndrome. Journal of psychosomatic research 59: 201-208, 2005.
2. Black CD, O'Connor P J, and McCully KK. Increased daily physical activity and fatigue symptoms in chronic fatigue syndrome. Dyn Med 4: 3, 2005.
3. Bradley AS FB, Bansal AS. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol 172: 73-80., 2013.
4. Broderick G, Ben-Hamo R, Vashishtha S, Efroni S, Nathanson L, Barnes Z, Fletcher MA, and Klimas N. Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis. Brain, behavior, and immunity 28: 159-169, 2013.
5. Buchwald D, Ashley RL, Pearlman T, Kith P, and Komaroff AL. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. Journal of medical virology 50: 25-30, 1996.
6. Cannon JG, Angel JB, Abad LW, Vannier E, Mileno MD, Fagioli L, Wolff SM, and Komaroff AL. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. Journal of clinical immunology 17: 253-261, 1997.
7. Cannon JG, Angel JB, Ball RW, Abad LW, Fagioli L, and Komaroff AL. Acute phase responses and cytokine secretion in chronic fatigue syndrome. Journal of clinical immunology 19: 414-421, 1999.
8. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, and Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. Journal of internal medicine 270: 327-338, 2011.
9. Demettre E, Bastide L, D'Haese A, De Smet K, De Meirleir K, Tiev KP, Englebi-enne P, and Lebleu B. Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. The Journal of biological chemistry 277: 35746-35751, 2002.
10. Englebienne P, Herst CV, De Smet K, D'Haese A, and De Meirleir K. Interactions between RNase L ankyrin-like domain and ABC transporters as a possible origin for pain, ion transport, CNS and immune disorders of chronic fatigue immune dysfunction syndrome. Journal of Chronic Fatigue Syndrome 8: 83-102, 2001.
11. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of internal medicine 121: 953-959, 1994.
12. Gerrity TR, Papanicolaou DA, Amsterdam JD, Bingham S, Grossman A, Hedrick T, Herberman RB, Krueger G, Levine S, Mohagheghpour N, Moore RC, Oleske J, and Snell CR. Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. Neuroimmunomodulation 11: 351-357, 2004.
13. Gupta S, Aggarwal S, and Starr A. Increased production of interleukin-6 by adherent and non-adherent mononuclear cells during 'natural fatigue' but not following 'experimental fatigue' in patients with chronic fatigue syndrome. International journal of molecular medicine 3: 209-213, 1999.
14. Heins M, Knoop H, Nijs J, Feskens R, Meeus M, Moorkens G, and Bleijenberg G. Influence of Symptom Expectancies on Stair-Climbing Performance in Chronic Fatigue Syndrome: Effect of Study Context. International journal of behavioral medicine 2012.
15. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, and et al. Chronic fatigue syndrome: a working case definition. Annals of internal medicine 108: 387-389, 1988.
16. Jammes Y, Steinberg JG, and Delliaux S. Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. Journal of internal medicine 272: 74-84, 2012.
17. Jammes Y, Steinberg JG, Delliaux S, and Bregeon F. Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses. Journal of internal medicine 266: 196-206, 2009.
18. Jammes Y, Steinberg JG, Mambrini O, Bregeon F, and Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. Journal of internal medicine 257: 299-310, 2005.
19. LaManca JJ, Sisto SA, Zhou XD, Ottenweller JE, Cook S, Peckerman A, Zhang Q, Denny TN, Gause WC, and Natelson BH. Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. Journal of clinical immunology 19: 135-142, 1999.
20. Lapp CW. Exercise limits in chronic fatigue syndrome. The American journal of medicine 103: 83-84, 1997.
21. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, and Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology 62: 23, 2009.
22. Light AR, Bateman L, Jo D, Hughen RW, Vanhaitsma TA, White AT, and Light KC. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. Journal of internal medicine 271: 64-81, 2012.
23. Light AR, White AT, Hughen RW, and Light KC. Moderate Exercise Increases Expression for Sensory, Adrenergic, and Immune Genes in Chronic Fatigue Syndrome Patients But Not in Normal Subjects. J Pain 2009.
24. Lloyd A, Gandevia S, Brockman A, Hales J, and Wakefield D. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 18: S142-146, 1994.
25. Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Current opinion in psychiatry 22: 75-83, 2009.
26. Maes M. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Progress in neuro-psychopharmacology & biological psychiatry 35: 784-794, 2011.
27. Maes M, Mihaylova I, Kubera M, and Bosmans E. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro endocrinology letters 28: 463-469, 2007.
28. Meeus M, Nijs J, McGregor N, Meeusen R, De Schutter G, Truijen S, Fremont M, Van Hoof E, and De Meirleir K. Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance. In vivo (Athens, Greece) 22: 115-121, 2008.
29. Moher D, Liberati A, Tetzlaff J, and Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151: 264-269, W264, 2009.
30. Nasralla M, Haier J, and Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 18: 859-865, 1999.
31. Natelson BH HM, Ponzio NM. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clinical and diagnostic laboratory immunology 9: 747-752, 2002.
32. Nijs J, and Fremont M. Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications. Expert opinion on therapeutic targets 12: 281-289, 2008.
33. Nijs J, Inghelbrecht E, Daenen L, Hachimi-Idrissi S, Hens L, Willems B, Roussel N, Cras P, Wouters K, and Bernheim J. Recruitment bias in chronic pain research: whiplash as a model. Clinical rheumatology 30: 1481-1489, 2011.
34. Nijs J, Meeus M, Heins M, Knoop H, Moorkens G, and Bleijenberg G. Kinesiopho-bia, catastrophizing and anticipated symptoms before stair climbing in chronic fatigue syndrome: an experimental study. Disability and rehabilitation 2012.
35. Nijs J, Meeus M, McGregor NR, Meeusen R, de Schutter G, van Hoof E, and de Meirleir K. Chronic fatigue syndrome: exercise performance related to immune dysfunction. Medicine and science in sports and exercise 37: 1647-1654, 2005.
36. Nijs J, Nicolson GL, De Becker P, Coomans D, and De Meirleir K. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS immunology and medical microbiology 34: 209-214, 2002.
37. Nijs J, Van Oosterwijck J, Meeus M, Lambrecht L, Metzger K, Fremont M, and Paul L. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta. Journal of internal medicine 267: 418-435, 2010.
38. Ohashi K, Yamamoto Y, and Natelson BH. Activity rhythm degrades after strenuous exercise in chronic fatigue syndrome. Physiology & behavior 77: 39-44, 2002.
39. Peterson PK, Sirr SA, Grammith FC, Schenck CH, Pheley AM, Hu S, and Chao CC. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clinical and diagnostic laboratory immunology 1: 222-226, 1994.
40. Player MR, and Torrence PF. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacology & therapeutics 78: 55-113, 1998.
41. Robinson M, Gray SR, Watson MS, Kennedy G, Hill A, Belch JJ, and Nimmo MA. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scandinavian journal of medicine & science in sports 20: 282-290, 2010.
42. Sargent C, Scroop GC, Nemeth PM, Burnet RB, and Buckley JD. Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome. Medicine and science in sports and exercise 34: 51-56, 2002.
43. Shetzline SE, and Suhadolnik RJ. Characterization of a 2',5'-oligoadenylate (2-5A)-dependent 37-kDa RNase L: azido photoaffinity labeling and 2-5A-dependent activation. The Journal of biological chemistry 276: 23707-23711, 2001.
44. Siegel SD, Antoni MH, Fletcher MA, Maher K, Segota MC, and Klimas N. Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup? Journal of psychosomatic research 60: 559-566, 2006.
45. Smylie AL, Broderick G, Fernandes H, Razdan S, Barnes Z, Collado F, Sol C, Fletcher MA, and Klimas N. A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome. BMC Immunol 14: 1471-2172, 2013.
46. Sorensen B, Jones JF, Vernon SD, and Rajeevan MS. Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med 15: 34-42, 2009.
47. Sorensen B, Streib JE, Strand M, Make B, Giclas PC, Fleshner M, and Jones JF. Complement activation in a model of chronic fatigue syndrome. The Journal of allergy and clinical immunology 112: 397-403, 2003.
48. Steinau M, Unger ER, Vernon SD, Jones JF, and Rajeevan MS. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med 82: 750-755, 2004.
49. Suarez A, Guillamo E, Roig T, Blazquez A, Alegre J, Bermudez J, Ventura JL, Gar-cia-Quintana AM, Comella A, Segura R, and Javierre C. Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J Womens Health 19: 1073-1077, 2010.
50. Suhadolnik RJ, Peterson DL, O'Brien K, Cheney PR, Herst CV, Reichenbach NL, Kon N, Horvath SE, Iacono KT, Adelson ME, De Meirleir K, De Becker P, Charubala R, and Pfleiderer W. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 17: 377-385, 1997.
51. Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Muller WE, Schroder HC, Carter WA, and et al. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18 Suppl 1: S96-104, 1994.
52. Swanink CM, Vercoulen JH, Galama JM, Roos MT, Meyaard L, van der Ven-Jongekrijg J, de Nijs R, Bleijenberg G, Fennis JF, Miedema F, and van der Meer JW. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. The Journal of infectious diseases 173: 460-463, 1996.
53. Thambirajah AA, Sleigh K, Stiver HG, and Chow AW. Differential heat shock protein responses to strenuous standardized exercise in chronic fatigue syndrome patients and matched healthy controls. Clinical and investigative medicine Medecine clinique et experimentale 31: E319-327, 2008.
54. Van Oosterwijck J, Nijs J, Meeus M, Lefever I, Huybrechts L, Lambrecht L, and Paul L. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. Journal of internal medicine 268: 265-278, 2010.
55. Wallman KE, Morton AR, Goodman C, Grove R, and Guilfoyle AM. Randomised controlled trial of graded exercise in chronic fatigue syndrome. The Medical journal of Australia 180: 444-448, 2004.
56. Walsh NP, Gleeson M, Shephard RJ, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, and Simon P. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 17: 6-63, 2011.
57. Whistler T, Jones JF, Unger ER, and Vernon SD. Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC physiology 5: 5, 2005.
58. White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, and Light KC. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology 47: 615-624, 2010.
59. White AT, Light AR, Hughen RW, Vanhaitsma TA, and Light KC. Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosomatic medicine 74: 46-54, 2012.
60. Zhao G, Zhou S, Davie A, and Su Q. Effects of moderate and high intensity exercise on T1/T2 balance. Exerc Immunol Rev 18: 98-114, 2012.